Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospective Cohort Study Patients with ...
When prostate cancer spreads, or metastasizes, its destination site is nearly always bone. The majority of men with prostate cancer that spreads outside of the prostate eventually experience bone ...
Studies evaluating the incidence and prevalence of CTIBL in early breast and prostate cancer patients and trials evaluating the preventative role of bisphosphonates were identified by a search of the ...
May 4, 2010 (Barcelona, Spain) — Monthly infusions of the bisphosphonate zoledronic acid significantly reduce the risk for bone fractures in men with prostate cancer and malignant bone metastases, ...
Zoledronic acid reduced fracture risk by 27% in men with metastatic prostate cancer receiving ADT in the STAMPEDE trial. Patients with non-metastatic disease showed no significant fracture benefit ...
The bone metastasis in solid tumors market is expanding due to rising incidences of metastasizing solid tumors like breast, prostate, lung cancer, and renal cell carcinoma. This growth is fueled by ...
CHICAGO (Reuters) - A third pivotal trial of Amgen Inc's denosumab found that it significantly delayed the likelihood of suffering fractures and other bone complications in men with advanced prostate ...
An experimental drug has successfully reduced hip and spine fractures in the two largest patient populations at risk for osteoporosis — postmenopausal women and men being treated for prostate cancer — ...
What is the best treatment for a 60-year-old man with prostate cancer that has metastasized to the spine? Gleason score is 9 and PSA is rising, now at 25 ng/mL. He was diagnosed 2 years ago, at which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results